Rchr
J-GLOBAL ID:202201000949331050   Update date: Aug. 30, 2023

Matsumoto Ari

マツモト アリ | Matsumoto Ari
Affiliation and department:
Research keywords  (4): CXCL11 ,  CXCL10 ,  CXCL9 ,  ケモカイン
Papers (3):
  • Ari Matsumoto, Miki Hiroi, Kazumasa Mori, Nobuharu Yamamoto, Yoshihiro Ohmori. Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line. Medical sciences (Basel, Switzerland). 2023. 11. 2
  • Ryosuke Ushio, Miki Hiroi, Ari Matsumoto, Kazumasa Mori, Nobuharu Yamamoto, Yoshihiro Ohmori. Enhanced Cytotoxic Effects in Human Oral Squamous Cell Carcinoma Cells Treated with Combined Methyltransferase Inhibitors and Histone Deacetylase Inhibitors. Biomedicines. 2022. 10. 4
  • Hana Yamaguchi, Miki Hiroi, Kazumasa Mori, Ryosuke Ushio, Ari Matsumoto, Nobuharu Yamamoto, Jun Shimada, Yoshihiro Ohmori. Simultaneous Expression of Th1- and Treg-Associated Chemokine Genes and CD4+, CD8+, and Foxp3+ Cells in the Premalignant Lesions of 4NQO-Induced Mouse Tongue Tumorigenesis. Cancers. 2021. 13. 8
Awards (1):
  • 2022/04 - 第76回NPO法人日本口腔科学会 Rising scientist賞 IFN誘導性ケモカインCXCL9、CXCL10,CXCL11のマウス扁平上皮癌細胞に対する抗腫瘍作用の違い
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page